Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has completed its acquisition of Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers. Snapdragon Chemistry specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, utilizing state-of-the-art automation technology and proprietary equipment to solve complex process and analytical development challenges.
Read the full article: Cambrex Completes Acquisition of Snapdragon Chemistry, a Leader in Continuous Flow API Development Services //
Source: https://www.prnewswire.com/news-releases/cambrex-completes-acquisition-of-snapdragon-chemistry-a-leader-in-continuous-flow-api-development-services-301723689.html